LYEL Lyell Immunopharma

Watchlist

0.582
+0.098+20.28%

Close Mar 19 16:00 ET

0.580
-0.002-0.31%

Post 19:56 ET

171.76MMarket Cap-0.44P/E (TTM)

About Lyell Immunopharma Company

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. Klausner, Stan Riddell, and Crystal Mackall in June 2018 and is headquartered in South San Francisco, CA.

Company Profile

SymbolLYEL

Company NameLyell Immunopharma

Listing DateJun 17, 2021

Issue Price17.00

Founded2018

CEODr. Lynn Seely,M.D.

MarketNASDAQ

Employees300

Fiscal Year Ends12-31

Address201 Haskins Way,Suite 101

CitySouth San Francisco

ProvinceCalifornia

CountryUnited States of America

Zip Code94080

Phone1-650-695-0677

Websitehttp://www.lyell.com

Company Executives

Name
Position
Salary

Dr. Lynn Seely,M.D.
Director, President and Chief Executive Officer
2.65M

Stephen Hill
Chief Operating Officer
3.11M

Charles Newton
Chief Financial Officer and Principal Accounting Officer
4.32M

Matthew Lang
Chief Business Officer
4.01M

Dr. Gary Lee, PhD
Chief Scientific Officer
2.23M

Richard D. Klausner
Chairman of the Board
310.75K

Dr. Sumant Ramachandra,M.D.,PhD
Director
--

Catherine J. Friedman
Lead Independent Director
330.25K

William J. Rieflin
Independent Director
301.75K

Robert Taylor Nelsen
Independent Director
286.75K

Dr. Otis W. Brawley,M.D.
Independent Director
290.75K

Dr. Elizabeth G. Nabel, M.D.
Independent Director
293.25K

LYEL Lyell Immunopharma

About Lyell Immunopharma Company

Company Profile

Company Executives

Trending Stocks